ClinicalTrials.gov
public full text
Public Domain
Premature Luteinization Prevention by GnRH Antagonist in Patients Undergoing IUI
Premature luteinization in patients undergoing IUI can occur in up to 24% of cycles. These patients, according to recent data, have a lower pregnancy rate than controls. The possibility to avoid premature luteinization with GnRH antagonist may restore the chances of achieving a pregnancy in these women.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- GnRH Agonist and Intrauterine Insemination#833831
- A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age#969680
- GnRH for Luteal Support in IVF/ICSI/FET Cycles#886672
- Comparison Between Testosterone and Estradiol Over the Homogenization of Follicular Cohort#896369
- Cryopreserved-thawed Embryo Transfer With or Without Gonadotropin Releasing Hormone Agonist#876083
Record · ID 872025
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive